The federal landscape around kratom shifted quickly in the fall of 2026. Here is where the 7‑OH crackdown actually stands as of October 2026 — what regulators did, what is still only proposed, and what it means for the natural leaf here in New Mexico.
What actually happened
Aug 26, 2026 — DEA emergency scheduling (synthetics only). The DEA placed three lab‑made compounds — mitragynine pseudoindoxyl (MGPI), MGM‑15, and MGM‑16 — into Schedule I on a temporary basis. The Justice Department said the action targets “deliberately manufactured and concentrated opioid products, not traditional botanical kratom.”
Oct 8, 2026 — New federal health recommendation. The U.S. Department of Health and Human Services issued a fresh scheduling recommendation for 7‑hydroxymitragynine (7‑OH).
Oct 14, 2026 — Revised DEA threshold plan. The DEA’s updated framework is set for Federal Register publication, opening a 30‑day notice period. Under it, a product is controlled if 7‑OH or MGPI exceeds 1 mg per gram (solids) or 1 mg per mL (liquids), or if the ratio of mitragynine to 7‑OH drops below 100:1. Controls would last two years, with a possible one‑year extension.
This month — a warning sign for the plant. Three U.S. Senators (Grassley, Lee, and Collins) urged the DEA to immediately schedule 7‑OH and to “consider scheduling the entire kratom plant.” The American Kratom Association supports scheduling 7‑OH but opposes any ban on the natural leaf, and says the letter misreads the science.
What this means for New Mexico
The reassuring part: nearly every federal action so far has been aimed squarely at concentrated and synthetic 7‑OH — the lab‑made gas‑station products — not at the natural leaf that hundreds of thousands of New Mexicans use safely. Even the DEA has repeatedly drawn that line.
The warning part: the senators’ letter shows the natural plant is now politically exposed. A blanket ban on natural kratom would not touch the real driver of harm — the synthetic 7‑OH already on shelves — while stripping a documented option from responsible adults and pushing them toward unregulated online markets.
That is exactly the gap the Kratom Consumer Protection Act (KCPA) closes: define natural kratom and synthetic 7‑OH as different things in New Mexico law, ban the synthetic and adulterated products outright, and regulate the natural leaf responsibly — lab‑tested, labeled, and age‑restricted.
Send your letter to lawmakers →
Sources: U.S. DOJ/DEA temporary scheduling order, Aug 26, 2026; DEA revised scheduling framework following the Oct 8, 2026 HHS recommendation (Federal Register notice Oct 14, 2026); U.S. Senate letter to DEA and FDA, Oct 2026. Educational information, not legal advice.